Affiliation:
1. Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, 95123 Catania, Italy
2. Clinical Toxicology Unit, University Hospital of Catania, 95123 Catania, Italy
3. Dipartimento del Farmaco, ASP Trapani, 91100 Trapani, Italy
Abstract
The European Medicine Agency (EMA) has defined Adverse Drug Reactions (ADRs) as “a noxious and unintended response to a medicine”, not including poisoning, accidental, or intentional overdoses. The ADR occurrence differs based on the approach adopted for defining and detecting them, the characteristics of the population under study, and the research setting. ADRs have a significant impact on morbidity and mortality, particularly among older adults, and represent a financial burden for health services. Between 30% and 60% of ADRs might be predictable and preventable, emerging as a result of inappropriate prescription, drug chemistry inherent toxicity, cell-specific drug toxicity, age- and sex-related anomalies in drug absorption, distribution, metabolism, and elimination (ADME), and drug–drug interactions (DDIs) in combination therapies or when a patient is treated with different drugs for concomitant disorders. This is particularly important in chronic diseases which require long-term treatments. Rapid developments in pharmacogenetics/genomics have improved the understanding of ADRs accompanied by more accurate prescriptions and reduction in unnecessary costs. To alleviate the burden of ADRs, especially in the elderly, interventions focused on pharmaceutical principles, such as medication review and reconciliation, should be integrated into a broader assessment of patients’ characteristics, needs, and health priorities. Digital health interventions could offer valuable solutions to assist healthcare professionals in identifying inappropriate prescriptions and promoting patient adherence to pharmacotherapies.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference162 articles.
1. Burden of Multimorbidity in Relation to Age, Gender and Immigrant Status: A Cross-Sectional Study Based on Administrative Data;Lenzi;BMJ Open,2016
2. Sirois, C., Domingues, N.S., Laroche, M.-L., Zongo, A., Lunghi, C., Guénette, L., Kröger, E., and Émond, V. (2019). Polypharmacy Definitions for Multimorbid Older Adults Need Stronger Foundations to Guide Research, Clinical Practice and Public Health. Pharmacy, 7.
3. Polypharmacy Prevalence among Older Adults Based on the Survey of Health, Ageing and Retirement in Europe;Giardini;Arch. Gerontol. Geriatr.,2018
4. High Prevalence of Poor Quality Drug Prescribing in Older Individuals: A Nationwide Report From the Italian Medicines Agency (AIFA);Onder;J. Gerontol. Ser. A,2014
5. How Healthy Is Community-Dwelling Elderly Population? Results from Southern Italy;Guerriero;Transl. Med. UniSa,2016
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献